The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease
Abstract
Autosomal-dominant polycystic kidney disease (ADPKD) is a common genetic disorder that frequently leads to renal failure. Mutations in polycystin-1 (PC1) underlie most cases of ADPKD, but the function of PC1 has remained poorly understood. No preventive treatment for this disease is available. Here, we show that the cytoplasmic tail of PC1 interacts with tuberin, and the mTOR pathway is inappropriately activated in cyst-lining epithelial cells in human ADPKD patients and mouse models. Rapamycin, an inhibitor of mTOR, is highly effective in reducing renal cystogenesis in two independent mouse models of PKD. Treatment of human ADPKD transplant-recipient patients with rapamycin results in a significant reduction in native polycystic kidney size. These results indicate that PC1 has an important function in the regulation of the mTOR pathway and that this pathway provides a target for medical therapy of ADPKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Nauli, S. M., Alenghat, F. J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A. E. H., Lu, W., Brown, E. M., Quinn, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1076 · Cited by 2,057
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1
Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., & Sabatini, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1432 · Cited by 1,138
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093
Rheb Binds and Regulates the mTOR Kinase
Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., & Avruch, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.053 · Cited by 1,005
Dysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Zhang, Y., Gao, X., Saucedo, L. J., Ru, B., Edgar, B. A., & Pan, D. (2003) · Nature Cell Biology · doi:10.1038/ncb999 · Cited by 923
Wilson, P. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022161 · Cited by 916
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Genetics and Pathogenesis of Polycystic Kidney Disease
Igarashi, P., & Somlo, S. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000028643.17901.42 · Cited by 593
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
Harada, H., Andersen, J. S., Mann, M., Terada, N., & Korsmeyer, S. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171301998 · Cited by 549
TSC2: filling the GAP in the mTOR signaling pathway
Li, Y. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.11.007 · Cited by 419
Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease
Tao, Y., Kim, J., Schrier, R. W., & Edelstein, C. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080660 · Cited by 391
Flechner, S. M., Goldfarb, D., Modlin, C., Feng, J., Krishnamurthi, V., Mastroianni, B., Savas, K., Cook, D. J., & Novick, A. C. (2002) · Transplantation · doi:10.1097/00007890-200210270-00002 · Cited by 375
Self-citationRenal Cystic Disease in Tuberous Sclerosis: Role of the Polycystic Kidney Disease 1 Gene
Sampson, J. R., Maheshwar, M. M., Aspinwall, R., Thompson, P., Cheadle, J. P., Ravine, D., Roy, S., Haan, E., Bernstein, J., & Harris, P. C. (1997) · The American Journal of Human Genetics · doi:10.1086/514888 · Cited by 373
Kenerson, H. L., Aicher, L. D., True, L. D., & Yeung, R. S. W. (2002) · PubMed · Cited by 315
Wahl, P. R., Serra, A. L., Le Hir, M., Molle, K. D., Hall, M. N., & Wüthrich, R. P. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi181 · Cited by 287
Molecular pathogenesis of ADPKD: The polycystin complex gets complex
Ong, A. C. M., & Harris, P. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00201.x · Cited by 242
TOR Mutations Confer Rapamycin Resistance by Preventing Interaction with FKBP12-Rapamycin
Lorenz, M. C., & Heitman, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27531 · Cited by 238
Luan, F. L., Ding, R., Sharma, V. K., James Chon, W., Lagman, M., & Suthanthiran, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00805.x · Cited by 206
VIP17/MAL, a lipid raft-associated protein, is involved in apical transport in MDCK cells
Cheong, K. H., Zacchetti, D., Schneeberger, E. E., & Simons, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6241 · Cited by 206
Syntaxin 2 and Endobrevin Are Required for the Terminal Step of Cytokinesis in Mammalian Cells
Low, S. H., Li, X., Miura, M., Kudo, N., Quiñones, B., & Weimbs, T. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00122-9 · Cited by 184
Self-citationFick-Brosnahan, G. M., Belz, M. M., McFann, K. K., Johnson, A. M., & Schrier, R. W. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33379 · Cited by 178
A Functional Floxed Allele of Pkd1 that Can Be Conditionally Inactivated In Vivo
Piontek, K. B., Huso, D. L., Grinberg, A., Liu, L., Bedja, D., Zhao, H., Gabrielson, K., Qian, F., Mei, C., Westphal, H., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000144204.01352.86 · Cited by 168
Self-citationTuberous sclerosis complex: from Drosophila to human disease
Pan, D., Dong, J., Zhang, Y., & Gao, X. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.006 · Cited by 159
Tuberin-Dependent Membrane Localization of Polycystin-1
Kleymenova, E., Ibraghimov‐Beskrovnaya, O., Kugoh, H., Everitt, J. I., Xu, H., Kiguchi, K., Landes, G. M., Harris, P. C., & Walker, C. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00226-x · Cited by 154
Tuberous sclerosis complex: genetics to pathogenesis
Narayanan, V. (2003) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2003.09.002 · Cited by 148
Scheffers, M. S., van der Bent, P., Prins, F., Spruit, L., Breuning, M. H., Litvinov, S. V., de Heer, E., & Peters, D. J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2743 · Cited by 133
Autosomal dominant polycystic kidney disease: Molecular genetics and pathophysiology
Sutter, M., & Germino, G. G. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2003.13 · Cited by 124
Self-citationNauta, J., Ozawa, Y., Sweeney, W. E., et al. (1993) · Pediatric Nephrology · doi:10.1007/bf00864387 · Cited by 120
Positional cloning of jcpk/bpk locus of the mouse
Bryda, E. C., Flaherty, L. A., Cogswell, C., Price, S. J., Hou, X., & Guay‐Woodford, L. M. (2003) · Mammalian Genome · doi:10.1007/s00335-002-2241-0 · Cited by 97
Cellular localization and tissue distribution of polycystin-1
Peters, D. J. M., van der Wal, A. M., Spruit, L., Saris, J. J., Breuning, M. H., Bruijn, J. A., & de Heer, E. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199908)188:4<439::aid-path367>3.0.co;2-p · Cited by 87
Alternative Splicing of the Tuberous Sclerosis 2 (TSC2) Gene in Human and Mouse Tissues
Xu, L., Sterner, C. J., Maheshwar, M. M., Wilson, P. J., Nellist, M. D., Short, P., Haines, J. L., Sampson, J. R., & Ramesh, V. (1995) · Genomics · doi:10.1006/geno.1995.1079 · Cited by 67
Cellular Activation Triggered by the Autosomal Dominant Polycystic Kidney Disease Gene Product PKD2
Arnould, T., Sellin, L. K., Benzing, T. R., Tsiokas, L., Cohen, H. T., Kim, E., & Walz, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3423 · Cited by 66
Self-citationBrown, N. E., & Murcia, N. S. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00863.x · Cited by 55
Self-citationFrank, M., Atanasoski, S., Sancho, S., Magyar, J. P., Rülicke, T., Schwab, M. E., & Suter, U. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751927.x · Cited by 31
Weimbs, T., Low, S. H., Li, X., & Kreitzer, G. E. (2003) · Methods · doi:10.1016/s1046-2023(03)00025-2 · Cited by 22
Self-citation
Cited by
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Harris, P. C., & Torres, V. E. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101707.125712 · Cited by 801
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Walz, G., Budde, K., Mannaa, M., Nürnberger, J., Wanner, C., Sommerer, C., Kunzendorf, U., Banas, B., Hörl, W. H., Obermüller, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003491 · Cited by 587
Self-citationAutosomal dominant polycystic kidney disease: the last 3 years
Torres, V. E., & Harris, P. C. (2009) · Kidney International · doi:10.1038/ki.2009.128 · Cited by 590
Metadata
- Authors
- Shillingford, J. M., Murcia, N. S., Larson, C. H., Low, S. H., Hedgepeth, R., Brown, N., Flask, C. A., Novick, A. C., Goldfarb, D. A., Kramer-Zucker, A., Walz, G., Piontek, K. B., Germino, G. G., & Weimbs, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-04-04
- Volume
- 103
- Issue
- 14
- Pages
- 5466-5471
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2141331673
- Cited by
- 808
- References
- 38
- FWCI
- 27.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.